{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:41:24Z","timestamp":1794966084101,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In patients affected by connective tissue diseases (CTDs), the identification of wide autoantibody profiles may prove useful in early diagnosis, in the evaluation of prognosis (risk stratification), and in predicting response to therapy. The aim of the present study was to evaluate the utility of multiparametric autoantibody analysis performed by a new fully automated particle-based multi-analyte technology (PMAT) digital system in a large multicenter cohort of CTD patients and controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Serum samples from 787 patients with CTD (166 systemic lupus erythematosus; 133 systemic sclerosis; 279 Sj\u00f6gren\u2019s syndrome; 106 idiopathic inflammatory myopathies; 103 undifferentiated CTD), 339 patients with other disorders (disease controls) (118 infectious diseases, 110 organ-specific autoimmune diseases, 111 other rheumatic diseases), and 121 healthy subjects were collected in 13 rheumatologic centers of the FIRMA group. Sera were analyzed with the Aptiva-PMAT instrument (Inova Diagnostics) for a panel of 29 autoantibodies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Multiparametric logistic regression showed that enlarged antibody profiles have a higher diagnostic efficiency than that of individual antibodies or of antibodies that constitute classification criteria for a given disease and that probability of disease increases with multiple positive autoantibodies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study that analyzes the clinical and diagnostic impact of autoantibody profiling in CTD. The results obtained with the new Aptiva-PMAT method may open interesting perspectives in the diagnosis and sub-classification of patients with autoimmune rheumatic diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02980-x","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:03:38Z","timestamp":1671793418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4227-6983","authenticated-orcid":false,"given":"Nicola","family":"Bizzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Villalta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Bini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Piantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emirena","family":"Garrafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Riccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bellisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ghirardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Palterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Parronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Infantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Benucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Rigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Arcarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Canti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"FIRMA Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onelia","family":"Bistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cafaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Topini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Masneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cheleschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Romana","family":"Bacarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cammelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia Rovere","family":"Querini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"key":"2980_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren syndrome: a consensus and data-driven methodology involving international patient cohorts. Ann Rheum Dis. 2017;76:9\u201316.","journal-title":"Ann Rheum Dis"},{"key":"2980_CR2","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis an American College of Rheumatology\/European League Against Rheumatism Collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"2980_CR3","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rlund A, Bottai M, Werth WP, Pilkington C, de Visser M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955\u201364.","journal-title":"Ann Rheum Dis"},{"key":"2980_CR4","first-page":"33","volume-title":"Mixed connective tissue diseases and antinuclear antibodies","author":"D Alarcon-Segovia","year":"1987","unstructured":"Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue diseases and antinuclear antibodies. Amsterdam: Elsevier; 1987. p. 33\u201340."},{"key":"2980_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2980_CR6","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis specific autoantibodies. JAMA Neurol. 2018;75:1528\u201337.","journal-title":"JAMA Neurol"},{"key":"2980_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jamaneurol.2019.0440","volume":"76","author":"JB Vulsteke","year":"2019","unstructured":"Vulsteke JB, De Langhe E, Mahler M. Autoantibodies at the center of (sub) classification-issues of detection. JAMA Neurol. 2019;76:867\u20138.","journal-title":"JAMA Neurol"},{"key":"2980_CR8","doi-asserted-by":"publisher","first-page":"e0214202","DOI":"10.1371\/journal.pone.0214202","volume":"14","author":"PD Burbelo","year":"2019","unstructured":"Burbelo PD, Gordon SM, Waldman M, Edison JD, Little DJ, Stitt RS, et al. Autoantibodies are present before the clinical diagnosis of systemic sclerosis. PLoS One. 2019;14:e0214202.","journal-title":"PLoS One"},{"key":"2980_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/art.41153","volume":"72","author":"SI Niyhianova","year":"2020","unstructured":"Niyhianova SI, Sari A, Harvey JC, Leslie A, Derrett-Smith EC, Fonseca C, et al. Using antibodies and cutaneous subsets to develop outcome-based disease classification in systemic sclerosis. Arthritis Rheum. 2020;72:465\u201376.","journal-title":"Arthritis Rheum"},{"key":"2980_CR10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.1780330505","volume":"33","author":"EJ ter Borg","year":"1990","unstructured":"ter Borg EJ, Horst G, Hummel EJ, Limburg PC, Kallenberg CG. Measurement of increases in anti-double stranded DNA antibody levels s a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum. 1990;33:934\u201343.","journal-title":"Arthritis Rheum"},{"key":"2980_CR11","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(95)90114-0","volume":"345","author":"H Bootsma","year":"1995","unstructured":"Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, et al. Prevention of relapses in systemic lupus erythematosus. Lancet. 1995;345:1595\u20139.","journal-title":"Lancet"},{"key":"2980_CR12","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053","volume":"117","author":"R Tozzoli","year":"2002","unstructured":"Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316\u201324.","journal-title":"Am J Clin Pathol"},{"key":"2980_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/08923973.2015.1077461","volume":"38","author":"M Mahler","year":"2016","unstructured":"Mahler M, Bentow C, Serra J, Fritzler MJ. Detection of autoantibodies using chemiluminescence technologies. Immunopharmacol Immunotoxicol. 2016;38:14\u201320.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2980_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s13317-017-0097-2","volume":"8","author":"L Cinquanta","year":"2017","unstructured":"Cinquanta L, Fontana DE, Bizzaro N. Chemiluminescent immunoassay technology: what does it change in autoantibody detection? Auto Immun Highlights. 2017;8:9.","journal-title":"Auto Immun Highlights"},{"key":"2980_CR15","first-page":"193","volume":"16","author":"T Carbone","year":"2020","unstructured":"Carbone T, Bizzaro N, Infantino M, Miconi V, Tozzoli R, Antico A, et al. National survey on behalf of the Italian Study Group on Autoimmunology: state of art of Italian autoimmune laboratories in 2019. Riv It Med Lab. 2020;16:193\u2013206.","journal-title":"Riv It Med Lab"},{"key":"2980_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","volume":"12","author":"X Bossuyt","year":"2020","unstructured":"Bossuyt X, de Langhe E, Borghi O, Meroni PL. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases. Nat Rev Rheumatol. 2020;12:715\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"2980_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","volume":"58","author":"D Villalta","year":"2020","unstructured":"Villalta D, Seaman A, Tiongson M, Warren C, Bentow C, Bizzaro N, et al. Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis. Clin Chem Lab Med. 2020;58:1499\u2013507.","journal-title":"Clin Chem Lab Med"},{"key":"2980_CR18","doi-asserted-by":"publisher","first-page":"112661","DOI":"10.1016\/j.jim.2019.112661","volume":"474","author":"I Cavazzana","year":"2019","unstructured":"Cavazzana I, Richards M, Bentow C, Seaman A, Fredi M, Giudizi MG, et al. Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. J Immunol Methods. 2019;474:112661.","journal-title":"J Immunol Methods"},{"key":"2980_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/rheumatology\/kez092","volume":"58","author":"M Richards","year":"2019","unstructured":"Richards M, Garc\u00eda-De La Torre I, Gonz\u00e1lez-Bello YC, V\u00e1zquez-Del Mercado M, Andrade-Ortega L, Medrano-Ram\u00edrez G, et al. Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy. Rheumatology. 2019;58:1655\u201361.","journal-title":"Rheumatology"},{"key":"2980_CR20","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.3390\/diagnostics11122246","volume":"11","author":"M Mahler","year":"2021","unstructured":"Mahler M, Malyavantham K, Seaman A, Bentow C, Anunciacion-Llunell A, Sanz-Mart\u00ednez MT, et al. Profiling of myositis specific antibodies and composite scores as an aid in the differential diagnosis of autoimmune myopathies. Diagnostics (Basel). 2021;11:2246.","journal-title":"Diagnostics (Basel)"},{"key":"2980_CR21","doi-asserted-by":"publisher","first-page":"102641","DOI":"10.1016\/j.autrev.2020.102641","volume":"19","author":"S Sciascia","year":"2020","unstructured":"Sciascia S, Radin M, Ramirez C, Seaman A, Bentow C, Casas S, et al. Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. Autoimmun Rev. 2020;19:102641.","journal-title":"Autoimmun Rev"},{"key":"2980_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3390\/biomedicines8120622","volume":"8","author":"M Radin","year":"2020","unstructured":"Radin M, Cecchi I, Foddai SG, Rubini E, Barinotti A, Ramirez C, et al. Validation of the Particle-Based Multi-Analyte technology for detection of anti-phosphatidylserine\/prothrombin antibodies. Biomedicines. 2020;8:622.","journal-title":"Biomedicines"},{"key":"2980_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.thromres.2021.03.019","volume":"202","author":"M Radin","year":"2021","unstructured":"Radin M, Foddai S, Cecchi I, Rubini E, Barinotti A, Mahler M, et al. Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine\/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. Thromb Res. 2021;202:100\u20133.","journal-title":"Thromb Res"},{"issue":"Suppl 3","key":"2980_CR24","first-page":"iii3","volume":"45","author":"M Gaubitz","year":"2006","unstructured":"Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology (Oxford). 2006;45(Suppl 3):iii3\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"2980_CR25","doi-asserted-by":"publisher","unstructured":"Chan EKL. Anti-Ro52 autoantibody is common in systemic autoimmune rheumatic diseases and correlating with worse outcome when associated with interstitial lung disease in systemic sclerosis and autoimmune myositis. Clin Rev Allergy Immunol. 2022. https:\/\/doi.org\/10.1007\/s12016-021-08911-z.","DOI":"10.1007\/s12016-021-08911-z"},{"key":"2980_CR26","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3389\/fimmu.2018.01146","volume":"9","author":"S McGlasson","year":"2018","unstructured":"McGlasson S, Wiseman S, Wardlaw J, Dhaun N, Hunt DPJ. Neurological disease in lupus: toward a personalized medicine approach. Front Immunol. 2018;9:1146.","journal-title":"Front Immunol"},{"key":"2980_CR27","doi-asserted-by":"publisher","first-page":"315179","DOI":"10.1155\/2014\/315179","volume":"2014","author":"M Mahler","year":"2014","unstructured":"Mahler M, Meroni PL, Bossuyt X, Fritzler MJ. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. J Immunol Res. 2014;2014:315179.","journal-title":"J Immunol Res"},{"key":"2980_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s13317-017-0098-1","volume":"8","author":"S Sirotti","year":"2017","unstructured":"Sirotti S, Generali E, Ceribelli A, Isailovic N, De Santis M, Selmi C. Personalized medicine in rheumatology: the paradigm of serum autoantibodies. Auto Immun Highlights. 2017;8:10.","journal-title":"Auto Immun Highlights"},{"key":"2980_CR29","first-page":"10","volume":"1","author":"M Fritzler","year":"2019","unstructured":"Fritzler M. Perspective: widening spectrum and gaps in autoantibody testing for systemic autoimmune diseases. J Rheumatol Res. 2019;1:10\u20138.","journal-title":"J Rheumatol Res"},{"key":"2980_CR30","first-page":"86","volume":"30","author":"N Bizzaro","year":"2019","unstructured":"Bizzaro N. Autoantibody profiles in autoimmune rheumatic diseases. Mediterr J Rheumatol. 2019;30:86\u20139.","journal-title":"Mediterr J Rheumatol"},{"key":"2980_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.autrev.2014.10.003","volume":"14","author":"G Yaniv","year":"2015","unstructured":"Yaniv G, Twig G, Ben-Ami Shor D, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14:75\u20139.","journal-title":"Autoimmun Rev"},{"key":"2980_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G, Chinoy H, Cooper RG, New RP, et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun. 2019;101:48\u201355.","journal-title":"J Autoimmun"},{"key":"2980_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jalm\/jfab132","volume":"7","author":"L Cinquanta","year":"2022","unstructured":"Cinquanta L, Infantino M, Bizzaro N. Detecting autoantibodies by multiparametric assays: impact on prevention, diagnosis, monitoring and personalized therapy in autoimmune diseases. J Appl Lab Med. 2022;7:137\u201350.","journal-title":"J Appl Lab Med"},{"key":"2980_CR34","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.jtauto.2021.100139","volume":"5","author":"M Infantino","year":"2021","unstructured":"Infantino M, Nagy E, Bizzaro N, Fischer K, Bossuyt X, Damoiseaux J. Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun. 2021;5:100139.","journal-title":"J Transl Autoimmun"},{"key":"2980_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jim.2018.05.014","volume":"459","author":"E Mummert","year":"2018","unstructured":"Mummert E, Fritzler MJ, Sj\u00f6wall C, Bentow C, Mahler M. The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination. J Immunol Methods. 2018;459:11\u20139.","journal-title":"J Immunol Methods"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02980-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:05:09Z","timestamp":1671793509000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02980-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2980"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02980-x","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Umbria Region, Italy (Authorization no. 3574\/19). Patients and healthy individuals gave their informed consent to this study. Records and information were anonymized and de-identified prior to analysis, according to the Declaration of Helsinki and to the Italian legislation (Authorization of the Privacy Guarantor No. 9, December 12, 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NB has received lecture fees from Inova Diagnostics. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}